Glaukos Corp. (GKOS)
108.67
+1.80
(+1.68%)
USD |
NYSE |
Dec 10, 15:37
Glaukos Cash from Investing (Quarterly): -3.993M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -502.00M |
| Perspective Therapeutics, Inc. | 13.99M |
| Xtant Medical Holdings, Inc. | 4.679M |
| VolitionRX Ltd. | 0.0012M |
| Catheter Precision, Inc. | -0.028M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.09M |
| Cash from Financing (Quarterly) | 5.264M |
| Free Cash Flow | -27.61M |
| Free Cash Flow Per Share (Quarterly) | -0.2043 |
| Free Cash Flow to Equity (Quarterly) | -11.02M |
| Free Cash Flow to Firm (Quarterly) | -10.53M |
| Free Cash Flow Yield | -0.45% |